2024    2023    2022    2021    2020    2019    2018    2017    2016   

2023

Articles

51 - 

Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

Kai Rejeski, Marion Subklewe, Mahmoud Aljurf, Emmanuel Bachy, Adriana Balduzzi, Pere Barba, Benedetto Bruno, Reuben Benjamin, Matteo Carrabba, Christian Chabannon et al.

Blood, 2023, 142 (10), pp.865-877.

DOI : https://doi.org/10.1182/blood.2023020578

Pubmed : 37300386

 

52 - 

Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial

Jean-Christophe Richard, Nicolas Terzi, Hodane Yonis, Fatima Chorfa, Florent Wallet, Claire Dupuis, Laurent Argaud, Bertrand Delannoy, Guillaume Thiery, Christian Pommier et al.

The Lancet Respiratory Medicine, 2023, 11 (11), pp.991-1002.

DOI : https://doi.org/10.1016/S2213-2600(23)00221-7

 

53 - 

Improving the decision to switch from first to second-line therapy in multiple sclerosis: a dynamic scoring system

C. Sabathe, Romain Casey, S. Vukusic, Emmanuelle Leray, G. Mathey, J. de Seze, J. Ciron, S. Wiertlewski, A. Ruet, J. Pelletier et al.

Multiple Sclerosis Journal, 2023, 29 (2), pp.236-247.

DOI : https://doi.org/10.1177/13524585221139156

Pubmed : 36515394

 

54 - 

Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma

Anais Schavgoulidze, Valérie Lauwers-Cances, Aurore Perrot, Titouan Cazaubiel, Marie-Lorraine Chretien, Philippe Moreau, Thierry Facon, Xavier Leleu, Lionel Karlin, Anne-Marie Stoppa et al.

Haematologica, 2023, 108 (5), pp.1374.

DOI : https://doi.org/10.3324/haematol.2021.280566

Pubmed : 36172814

 

55 - 

KDM6B drives epigenetic reprogramming associated with lymphoid stromal cell early commitment and immune properties

Marvin Sylvestre, Nicolas Barbier, Vonick Sibut, Saba Nayar, Céline Monvoisin, Simon Leonard, Julien Saint-Vanne, A Martín, Marion Guirriec, Maelle Latour et al.

Science Advances , 2023, Science Advances, 9 (48), pp.eadh2708.

DOI : https://doi.org/10.1126/sciadv.adh2708

Pubmed : 38019914

 

56 - 

Enteral citrulline supplementation versus placebo on SOFA score on day 7 in mechanically ventilated critically ill patients: the IMMUNOCITRE randomized clinical trial

Jean-Marc Tadie, Clara Locher, Adel Maamar, Jean Reignier, Pierre Asfar, Morgane Commereuc, Mathieu Lesouhaitier, Murielle Grégoire, Estelle Le Pabic, Claude Bendavid et al.

Critical Care, 2023, 27 (1), pp.381.

DOI : https://doi.org/10.1186/s13054-023-04651-y

Pubmed : 37784110

 

57 - 

Clinical features and outcomes of patients admitted to the ICU for Cyclophosphamide-associated cardiac toxicity: a retrospective cohort

Alice Vennier, Emmanuel Canet, Vianney Guardiolle, Florian Reizine, Jean-Noël Trochu, Thierry Le Tourneau, Cyrille Touzeau, Roch Houot, Amélie Séguin, Jean Reignier et al.

Supportive Care in Cancer, 2023, 31 (8),

DOI : https://doi.org/10.1007/s00520-023-07951-9

Pubmed : 37462731

 

58 - 

An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue-derived MSCs for research purposes

Sowmya Viswanathan, Katarina Le Blanc, Rachele Ciccocioppo, Georges Dagher, Anthony J Filiano, Jacques Galipeau, Mauro Krampera, Lena Krieger, Manoj M Lalu, Jan Nolta et al.

Cytotherapy, 2023, 25 (8), pp.803-807.

DOI : https://doi.org/10.1016/j.jcyt.2023.04.005

Pubmed : 37149800

 

59 - 

Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients

Pierre Walczak, Sylvain Choquet, Jacques Dantal, David Boutboul, Felipe Suarez, Marine Baron, Veronique Morel, Thomas Cluzeau, Mohamed Touati, Michelle Elias et al.

Haematologica, 2023, 108 (10), pp.2814-2819.

DOI : https://doi.org/10.3324/haematol.2022.282297

Pubmed : 36891749

 

60 - 

Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study

Michael Wang, Javier Munoz, Andre Goy, Frederick Locke, Caron Jacobson, Brian Hill, John Timmerman, Houston Holmes, Samantha Jaglowski, Ian Flinn et al.

Journal of Clinical Oncology, 2023, 41 (3), pp.555-567.

DOI : https://doi.org/10.1200/JCO.21.02370

Pubmed : 35658525